Rapport Therapeutics Inc.

01/09/2025 | Press release | Distributed by Public on 01/09/2025 08:13

CORRECTION -- Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders